Related Experiment Video
Updated: Jun 18, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Recognizing and meeting the challenge of Chagas disease in the USA
Jason Bowling1, Elizabeth A Walter
1Infectious Diseases Fellow University of Texas Health Science Center San Antonio, Mail Code 7881, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. bowling@uthscsa.edu
Insights
Over 300,000 individuals in the USA have Chagas disease, a parasitic infection. Healthcare providers need increased awareness for diagnosis and management, especially concerning blood screening and transmission.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- Chagas disease affects over 300,000 people in the USA.
- An estimated 30,000 new cases of Chagas cardiomyopathy are expected annually.
- The disease's epidemiology in the USA presents unique challenges compared to Central and South America.
Purpose of the Study:
- To highlight the distinct epidemiological features of Chagas disease in the USA.
- To emphasize the critical need for healthcare practitioner awareness and updated management strategies.
- To underscore the importance of blood bank screening, organ donation protocols, and addressing vertical transmission.
Main Methods:
- Review of current epidemiological data on Chagas disease in the USA.
- Analysis of challenges in diagnosis and management specific to the US healthcare system.
- Identification of key areas for public health intervention and clinical practice.
Main Results:
- Significant Chagas disease burden in the USA with substantial projected cardiomyopathy cases.
- Divergent epidemiological patterns necessitate tailored approaches in the USA.
- Critical need for enhanced vigilance in blood screening, organ donation, and vertical transmission prevention.
Conclusions:
- Heightened awareness of Chagas disease is crucial for US healthcare practitioners in differential diagnosis.
- Specific management recommendations for Chagas disease patients in the USA are essential.
- Further research is required to determine optimal treatment benefits for all patients and to develop new therapeutic agents.
Abstract:
It is estimated that over 300,000 people with Chagas disease are living in the USA, with more than 30,000 cases of Chagas cardiomyopathy expected per year. The epidemiology of Chagas disease in Central and South America differs from that of the USA, where particular attention must focus on blood bank screening, organ donation and vertical transmission. It is essential that healthcare practitioners have heightened awareness of Chagas disease in the differential diagnosis of certain patients and are aware of recommendations for the management of these patients in the USA. Ongoing attention must focus on trials that determine whether all patients will benefit from treatment as well as studies of new agents for therapy.
More Related Videos
Related Concept Videos
American Trypanosomiasis
Toxoplasmosis
Leishmaniasis
Infectious Diseases and Their Occurrence
Trichomoniasis
Principles of Disease Surveillance

